A phase II trial of temsirolimus and bevacizumab in patients with endometrial, ovarian, hepatocellular carcinoma, carcinoid, or islet cell cancer: Ovarian cancer (OC) subset—A study of the Princess Margaret, Mayo, Southeast phase II, and California Cancer (CCCP) N01 Consortia NCI#8233.
2011; Lippincott Williams & Wilkins; Volume: 29; Issue: 15_suppl Linguagem: Inglês
10.1200/jco.2011.29.15_suppl.5015
ISSN1527-7755
AutoresR.J. Morgan, Amit M. Oza, Rui Qin, Kristina Laumann, Helen Mackay, Elizabeth L. Strevel, Stephen Welch, Dan M. Sullivan, R.M. Wenham, H. X. Chen, L. Austin Doyle, David R. Gandara, Charles Erlichman,
Tópico(s)Renal cell carcinoma treatment
Resumo5015
Referência(s)